ARTICLE | Clinical News
AYX1: Ph II ADYX-004 started
March 14, 2017 7:53 PM UTC
Adynxx began the double-blind, placebo-controlled, U.S. Phase II ADYX-004 trial to evaluate single intrathecal injections of 660 mg AYX1 given prior to intrathecal administration of spinal anesthetic ...
BCIQ Company Profiles
BCIQ Target Profiles